The Head of Rare Diseases, US Medical is a critical leadership role within the US Medical organization, accountable for the strategic direction and execution of medical affairs activities across the Rare Diseases portfolio. This includes both marketed and pipeline assets in Spinal Muscular Atrophy (SMA), Amyotrophic Lateral Sclerosis (ALS), and Friedreich's Ataxia (FA), among other emerging indications. The portfolio spans early access programs, lifecycle management studies, and multiple launched therapies, each supporting patients with high unmet needs and representing major growth opportunities for Biogen. As a key member of the North America Medical Leadership Team, this leader will report to the Head of Medical, North America. They will oversee a cross-functional medical team including Medical Directors, Field Director, and Medical Science Liaisons (MSLs), while collaborating closely with Global Medical teams, Regulatory, US Commercial, Market Access, and Value & Evidence Generation partners. This individual will represent the Rare Diseases medical perspective across senior leadership forums and ensure that the strategic priorities of the therapeutic area are aligned with broader corporate goals, all while advancing scientific knowledge, clinical impact, and patient outcomes. You are a purpose-driven and strategic medical leader with a passion for advancing care in rare and complex diseases. You have experience leading medical teams, building collaborative relationships across stakeholders, and delivering meaningful impact for patients and the business. You thrive in complexity, operate with integrity, and create environments where high performance and empathy can co-exist.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Industry
Chemical Manufacturing
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees